Goat Anti-GST IgG:Eu-W1024

Goat Anti-GST IgG:Eu-W1024 （订货以CAS编码或英文名称为准）

Application|High-Throughput Screening||Application|TR-FRET||Product Type|Antibodies|Epitope Tag Antibodies|GST||Product Type|Antibodies|Primary Antibodies|Polyclonal Antibodies||Research Area

创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载

编号：PC55273

分子式：C20H24CLNO4

CAS号：127017-74-7

分子量：377.86

储存条件：2-8

申请试用

货号	品牌	规格	纯度/含量	标准价	优惠价
PC55273-10mg	Medlife	10mg	≥95%	待询	登录后可见
PC55273-25mg	Medlife	25mg	≥95%	待询	登录后可见
PC55273-50mg	Medlife	50mg	≥95%	待询	登录后可见
PC55273-100mg	Medlife	100mg	≥95%	待询	登录后可见
PC55273-50µg	Medlife	EA		¥14917.00	登录后可见
PC55273-1mg	Medlife	EA		¥63157.00	登录后可见
PC55273-20µg	Medlife	EA		¥7537.00	登录后可见

中文名称：	盐酸帕罗西汀半水EP杂质B HCl
中文别名：	帕罗西汀杂质B;外消旋-反式-4-脱氟-4-甲氧基帕罗西汀盐酸盐;盐酸帕罗西汀半水EP杂质B HCl;帕罗西汀甲氧基杂质;帕罗西汀USP相关物质A;帕罗西汀USP RC A
英文名称：	Goat Anti-GST IgG:Eu-W1024
英文别名：	rac-trans-4-Desfluoro-4-methoxy Paroxetine Hydrochloride;rac-trans-4-Defluoro-4-methoxy Paroxetine Hydrochloride;(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-methoxyphenyl)piperidine,hydrochloride;Paroxetine USP RC A;Paroxetine impurity B;Paroxetine EP IMpurity B;Paroxetine EP IMpurity B (USP RC A);Paroxetine HCl Hemihydrate EP Impurity B HCl;trans-4-(p-Methoxyphenyl)-3-[(3,4-methylenedioxy) phenoxy]methylpiperidine hydrochloride;(3R,4S)-rel-3-[(1,3-Benzodioxol-5-yloxy)Methyl]-4-(4-Methoxyphenyl)piperidine Hydrochloride
CAS号：	127017-74-7
分子式：	C20H24CLNO4
分子量：	377.86
详细描述	Application\|High-Throughput Screening\|\|Application\|TR-FRET\|\|Product Type\|Antibodies\|Epitope Tag Antibodies\|GST\|\|Product Type\|Antibodies\|Primary Antibodies\|Polyclonal Antibodies\|\|Research Area

搜索质检报告(COA)

相关产品

((3R,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol compound with ((3S,4S)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol (1:1) hydrochloride

(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro- [1,1'-biphenyl]-4-yl)piperidine-1-carboxylate

(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- methoxyphenyl)piperidine-1-carboxylate

(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound with (3S,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine(1:1) hydrochloride

(3S,3'S,4R,4'R)-diphenyl 3,3'-(oxybis(methylene))bis(4-(4- fluorophenyl)piperidine-1-carboxylate)

(3S,4R)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-phenyl piperidine-1-carboxylate

((cis)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methyl 4-methylbenzenesulfonate

(3S,3'S,4R,4'R)-3,3'-(oxybis(methylene))bis(4-(4-fluorophenyl)-1- methylpiperidine)

(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro-[1,1'- biphenyl]-3-yl)piperidine hydrochloride

(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro-[1,1'-biphenyl]-4-yl)-1-methylpiperidine hydrochloride